Morgan Stanley’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.46M | Buy |
237,879
+64,018
| +37% | +$2.01M | ﹤0.01% | 3719 |
|
|
2025
Q1 | $5.16M | Buy |
173,861
+43,220
| +33% | +$1.28M | ﹤0.01% | 3898 |
|
|
2024
Q4 | $3.85M | Sell |
130,641
-274,184
| -68% | -$8.09M | ﹤0.01% | 4214 |
|
|
2024
Q3 | $12.6M | Sell |
404,825
-464,039
| -53% | -$14.4M | ﹤0.01% | 3248 |
|
|
2024
Q2 | $29.4M | Buy |
868,864
+67,590
| +8% | +$2.29M | ﹤0.01% | 2251 |
|
|
2024
Q1 | $52.1M | Sell |
801,274
-1,032,852
| -56% | -$67.1M | ﹤0.01% | 1722 |
|
|
2023
Q4 | $125M | Buy |
1,834,126
+873,038
| +91% | +$59.6M | 0.01% | 1503 |
|
|
2023
Q3 | $49.9M | Buy |
961,088
+148,466
| +18% | +$7.71M | 0.01% | 1583 |
|
|
2023
Q2 | $48.7M | Buy |
812,622
+16,131
| +2% | +$967K | ﹤0.01% | 1592 |
|
|
2023
Q1 | $39.4M | Buy |
796,491
+441,769
| +125% | +$21.8M | ﹤0.01% | 1765 |
|
|
2022
Q4 | $20.2M | Buy |
354,722
+204,972
| +137% | +$11.7M | ﹤0.01% | 2333 |
|
|
2022
Q3 | $7.03M | Buy |
149,750
+126,403
| +541% | +$5.93M | ﹤0.01% | 3342 |
|
|
2022
Q2 | $871K | Buy |
23,347
+20,995
| +893% | +$783K | ﹤0.01% | 5099 |
|
|
2022
Q1 | $70K | Buy |
2,352
+947
| +67% | +$28.2K | ﹤0.01% | 6523 |
|
|
2021
Q4 | $48K | Sell |
1,405
-916
| -39% | -$31.3K | ﹤0.01% | 6832 |
|
|
2021
Q3 | $86K | Buy |
2,321
+2,301
| +11,505% | +$85.3K | ﹤0.01% | 6455 |
|
|
2021
Q2 | $1K | Sell |
20
-15,187
| -100% | -$759K | ﹤0.01% | 7614 |
|
|
2021
Q1 | $648K | Buy |
+15,207
| New | +$648K | ﹤0.01% | 5010 |
|